Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
901 to 920 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Repurposing cabozantinib with therapeutic potential in KIT-driven t(8;21) acute myeloid leukaemias. | Cancer Gene Ther | 2022 | 33833412 | PubTator, text mining | PubMed |
| The duality of PRDM proteins: epigenetic and structural perspectives. | FEBS J | 2022 | 33774927 | PubTator, text mining | PubMed |
| Clinical significance of RAS pathway alterations in pediatric acute myeloid leukemia. | Haematologica | 2022 | 33730843 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways mediating sorafenib resistance in acute myeloid leukemia. | Haematologica | 2022 | 33375770 | PubTator, text mining | PubMed |
| Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease. | Semin Cancer Biol | 2022 | 33220460 | PubTator, text mining | PubMed |
| Cytogenetic characteristics of and prognosis for acute myeloid leukemia in 107 children. | Asian Biomed (Res Rev News) | 2021 | 37551405 | PubTator, text mining | PubMed |
| Volunteer unrelated donor cell-derived acute myeloid leukemia with RUNX1-RUNX1T1. | EJHaem | 2021 | 35845276 | PubTator, text mining | PubMed |
| Preleukemic fusion genes typical for acute myeloid leukemia. | Vnitr Lek | 2021 | 35459386 | PubTator, text mining | PubMed |
| Small nucleolar RNA is potential as a novel player in leukemogenesis and clinical application. | Blood Sci | 2021 | 35402848 | PubTator, text mining | PubMed |
| Single-Cell Technologies to Decipher the Immune Microenvironment in Myeloid Neoplasms: Perspectives and Opportunities. | Front Oncol | 2021 | 35186713 | PubTator, text mining | PubMed |
| IGF2BP2 Induces U251 Glioblastoma Cell Chemoresistance by Inhibiting FOXO1-Mediated PID1 Expression Through Stabilizing lncRNA DANCR. | Front Cell Dev Biol | 2021 | 35141227 | PubTator, text mining | PubMed |
| Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia. | Transl Cancer Res | 2021 | 35116428 | PubTator, text mining | PubMed |
| Extraordinarily elevated CD33 expression in CD56+CD3- cells in the bone marrow of a patient with relapsed acute myeloid leukemia: a case report. | Transl Cancer Res | 2021 | 35116354 | PubTator, text mining | PubMed |
| Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia. | Front Genet | 2021 | 35111195 | PubTator, text mining | PubMed |
| A Predictor Combining Clinical and Genetic Factors for AML1-ETO Leukemia Patients. | Front Oncol | 2021 | 35096581 | PubTator, text mining | PubMed |
| Structural Analysis of SMYD3 Lysine Methyltransferase for the Development of Competitive and Specific Enzyme Inhibitors. | Diseases | 2021 | 35076487 | PubTator, text mining | PubMed |
| Preemptive Immunotherapy for Minimal Residual Disease in Patients With t(8;21) Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation. | Front Oncol | 2021 | 35070977 | PubTator, text mining | PubMed |
| [Analysis of risk factors of relapse after allogeneic hematopoietic stem cell transplantation in patients with t (8;21) acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 35045670 | PubTator, text mining | PubMed |
| [Chinese consensus on minimal residual disease detection and interpretation of patients with acute myeloid leukemia (2021)]. | Zhonghua Xue Ye Xue Za Zhi | 2021 | 35045649 | PubTator, text mining | PubMed |
| Potential biomarkers and signaling pathways associated with the pathogenesis of primary salivary gland carcinoma: a bioinformatics study. | Genomics Inform | 2021 | 35012286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=46